Friday Market Pulls Back, Led by Mag Seven Decline | Live Stock
RAPT Upgraded at H.C. Wainwright on China Licensing Deal
Assembly Bio Spikes After Early-stage Data for Gilead-partnered Hep B Therapy
RAPT Rockets 180% on Licensing Deal, $150M Private Placement
Arm Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Tonix Pharmaceuticals Announces PDUFA Goal Date Of August 15, 2025, For FDA Decision On U.S. Marketing Approval For TNX-102 SL For Fibromyalgia
86866 OP : Good entry level now , buy low . . .